RAND Corporation experts can address the potential health care impacts of the Inflation Reduction Act that was passed by the U.S. Senate on August 7. Those topics include the implications of allowing Medicare to negotiate prices directly with drug manufacturers for some medications, capping Medicare Part D out-of-pocket costs, and continuing enhanced health insurance subsidies for people who buy insurance through Affordable Care Act exchanges.
Republicans who buy individual health plans may be less likely to shop through marketplaces created under the federal Affordable Care Act, leading them to forgo subsidies provided by the federal government.
On November 19, 2020, the RAND Corporation convened a Technical Expert Panel (TEP) web meeting to gather input about stratified reporting of performance and approaches to reduce disparities in Medicare Advantage (MA) and Part D Contracts.
Examples of low-value health care include prescribing opioids for acute back pain and antibiotics for upper respiratory infections. Despite efforts to better educate clinicians and discourage wasteful care, spending on such services among Medicare recipients dropped only marginally from 2014 to 2018.
Comparing pre- and post-ACA periods, private dental insurance increased by 4.6% (P=0.013) and annual dental visits were unchanged (2.7%, P=0.071) comparing children likely or unlikely to be affected by the ACA.
We provide new evidence on causal factors behind geographic variation in health care utilization by examining changes in health care use for the near-elderly as they transition from being uninsured into Medicare.
On July 22, 2020, the RAND Corporation convened a Technical Expert Panel (TEP) web meeting to gather input on analyses that could be conducted to further enhance the Medicare Advantage (MA) and Part D Contract Star Ratings program.